A clinical overview of treatment decisions in the management of spasticity

✍ Scribed by Mark E. Gormley; Jr.; Christopher F. O'Brien; Stuart A. Yablon

• Publisher: John Wiley and Sons
• Year: 1997
• Tongue: English
• Weight: 214 KB
• Volume: 20
• Category: Article
• ISSN: 0148-639X
• DOI: 10.1002/(sici)1097-4598(1997)6+<14::aid-mus3>3.0.co;2-m

✦ Synopsis

Spasticity from an upper motor neuron syndrome may cause a variety of symptoms that interfere with function. Decisions regarding spasticity treatment are influenced by the chronicity, severity, and distribution of the spasticity; the locus of injury; the presence and severity of co-morbidities; the availability of support; and the goals of treatment. Not all spasticity can or even should be treated; tone reduction is indicated only if spasticity interferes with some level of function, positioning, care, or comfort. Treatment goals should be well outlined before treatment begins. Botulinum toxin may be used to treat focal spasticity as part of an overall treatment plan.